down arrow

SPARC

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE232I01014
  • NSEID: SPARC
  • BSEID: 532872
INR
145.40
2.9 (2.04%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 3.2 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

144.30149.55

52 Week

109.20431.10
Valuation
Technical
Day's Volume

CASH

3.2 lacs (-61.06%) Volume

Shareholding (Dec 2024)

FII

2.23%

Held by 61 FIIs

DII

0.64%

Held by 2 DIIs

Promoter

65.67%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Net Sales has grown by an annual rate of -15.14% and Operating profit at -20.78% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -105.82
2

The company has declared Negative results for the last 6 consecutive quarters

3

Stock is technically in a Mildly Bearish range

4

Risky - Negative EBITDA

5

Despite the size of the company, domestic mutual funds hold only 1.47% of the company

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 4,719 Cr (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.88

stock-summary
Return on Equity

-313.10%

stock-summary
Price to Book

37.04

Revenue and Profits (1 Year):
Net Sales:
15 Cr
(Quarterly Results - Dec 2024)
Net Profit:
-80 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-31.72%
0%
-31.72%
1 Year
-66.27%
0%
-66.27%
2 Years
-20.76%
0%
-20.76%
3 Years
-49.81%
0%
-49.81%
4 Years
-13.43%
0%
-13.43%
5 Years
19.08%
0%
19.08%

SPARC for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-15.14%
EBIT Growth (5y)
-20.78%
EBIT to Interest (avg)
-105.82
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.06
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
2.86%
ROCE (avg)
-123.15%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
37.04
EV to EBIT
-11.52
EV to EBITDA
-11.85
EV to Capital Employed
301.11
EV to Sales
73.84
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-2774.11%
ROE (Latest)
-313.10%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 13 Schemes (0.51%)

FIIs

Held by 61 FIIs (2.23%)

Promoter with highest holding

Shanghvi Finance Private Limited (42.28%)

Highest Public shareholder

Sun Pharmaceutical Industries Key Employees Benefit Trust (3.18%)

Individual Investors Holdings

18.89%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 15.94% vs -23.50% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 25.98% vs -11.20% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "14.91",
          "val2": "12.86",
          "chgp": "15.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-74.38",
          "val2": "-103.85",
          "chgp": "28.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.77",
          "val2": "1.11",
          "chgp": "149.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-79.71",
          "val2": "-107.69",
          "chgp": "25.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-498.86%",
          "val2": "-807.54%",
          "chgp": "308.68%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -34.26% vs -24.78% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -12.52% vs -20.58% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "29.67",
          "val2": "45.13",
          "chgp": "-34.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-198.97",
          "val2": "-193.65",
          "chgp": "-2.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.63",
          "val2": "0.52",
          "chgp": "213.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-204.53",
          "val2": "-181.77",
          "chgp": "-12.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-670.61%",
          "val2": "-429.09%",
          "chgp": "-241.52%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -24.43% vs -69.13% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -1.00% vs -100.16% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "44.58",
          "val2": "58.99",
          "chgp": "-24.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-273.35",
          "val2": "-296.27",
          "chgp": "7.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.40",
          "val2": "0.78",
          "chgp": "464.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-284.24",
          "val2": "-281.42",
          "chgp": "-1.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-613.17%",
          "val2": "-502.24%",
          "chgp": "-110.93%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -68.36% vs 73.97% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -74.37% vs -9.43% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "75.55",
          "val2": "238.78",
          "chgp": "-68.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-403.79",
          "val2": "-214.06",
          "chgp": "-88.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.66",
          "val2": "7.63",
          "chgp": "-78.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-388.11",
          "val2": "-222.58",
          "chgp": "-74.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-534.47%",
          "val2": "-89.65%",
          "chgp": "-444.82%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
14.91
12.86
15.94%
Operating Profit (PBDIT) excl Other Income
-74.38
-103.85
28.38%
Interest
2.77
1.11
149.55%
Exceptional Items
0.00
0.00
Standalone Net Profit
-79.71
-107.69
25.98%
Operating Profit Margin (Excl OI)
-498.86%
-807.54%
308.68%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 15.94% vs -23.50% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is 25.98% vs -11.20% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
29.67
45.13
-34.26%
Operating Profit (PBDIT) excl Other Income
-198.97
-193.65
-2.75%
Interest
1.63
0.52
213.46%
Exceptional Items
0.00
0.00
Standalone Net Profit
-204.53
-181.77
-12.52%
Operating Profit Margin (Excl OI)
-670.61%
-429.09%
-241.52%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -34.26% vs -24.78% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is -12.52% vs -20.58% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
44.58
58.99
-24.43%
Operating Profit (PBDIT) excl Other Income
-273.35
-296.27
7.74%
Interest
4.40
0.78
464.10%
Exceptional Items
0.00
0.00
Standalone Net Profit
-284.24
-281.42
-1.00%
Operating Profit Margin (Excl OI)
-613.17%
-502.24%
-110.93%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -24.43% vs -69.13% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is -1.00% vs -100.16% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
75.55
238.78
-68.36%
Operating Profit (PBDIT) excl Other Income
-403.79
-214.06
-88.63%
Interest
1.66
7.63
-78.24%
Exceptional Items
0.00
0.00
Standalone Net Profit
-388.11
-222.58
-74.37%
Operating Profit Margin (Excl OI)
-534.47%
-89.65%
-444.82%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -68.36% vs 73.97% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is -74.37% vs -9.43% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Sun Pharma Advanced Research Company Ltd stock-summary
stock-summary
Sun Pharma Advanced Research Company Ltd
Small Cap
Pharmaceuticals & Drugs
Sun Pharma Advanced Research Company Ltd. (SPARC) is a clinical stage bio-pharmaceutical company engaged in creating new drugs and delivery systems. The Company works on innovation and new product development for global markets. They undertake projects in research and technology for new chemical entities (NCE's) or new molecules, and novel drug delivery systems (NDDS). Sun Pharmaceutical Advanced Research Company Ltd was incorporated on March 1, 2006 as an innovative and development company.
Company Coordinates stock-summary
Company Details
Sun Pharma Advanced Res Centre, Akota Road Akota Vadodara Gujarat : 390020
stock-summary
Tel: 91-265-2330815/2339257
stock-summary
http://www.sparc.life
stock-summary
secretarial@sparcmail.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."